the european medicines agency is to review all drugs in the same class as Vioxx .
the drug was pulled from the market on sept. 30 after a study showed it increased the risk of heart attacks and strokes .
a new class-action lawsuit against the drug could cost the company up to $12 billion, lawyers say .
"this is confirmation of the drug's dangers," one lawyer says .
